ANN RICHMOND

Has grant

Professor

Vanderbilt University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Developing new therapies for melanoma

Open Date:

Close Date:

Grant: Close

CDK4/6 Inhibitors and MDM2 antagonists to treat melanoma

Open Date:

Close Date:

Grant: Close

Chemokines in the Pre-metastatic Niche

Open Date:

Close Date:

Articles (8)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (3)

Anna Vilgelm

Assistant Professor

Ohio State University

UNITED STATES

View details

Jin Chen

Vanderbilt University

UNITED STATES

View details

Deanna Edwards

Research Assistant Professor

Vanderbilt University Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

ANN RICHMOND

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (8)

Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma

Loss of Vascular Endothelial Glutaminase Inhibits Tumor Growth and Metastasis, and Increases Sensitivity to Chemotherapy

Immunomodulatory Properties of PI3K/AKT/mTOR and MAPK/MEK/ERK Inhibition Augment Response to Immune Checkpoint Blockade in Melanoma and Triple-Negative Breast Cancer

Proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patients

Suppressing MDSC Recruitment to the Tumor Microenvironment by Antagonizing CXCR2 to Enhance the Efficacy of Immunotherapy

Inhibition of the PI3K/mTOR Pathway in Breast Cancer to Enhance Response to Immune Checkpoint Inhibitors in Breast Cancer

Targeted Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity

Th9 and Th17 cells: the controversial twins in cancer immunity

Collaborators (3)

Anna Vilgelm

Jin Chen

Deanna Edwards

Make your next move.